register

News & Trends - Pharmaceuticals

Pharmacy Guild supports real time monitoring of opioids

Health Industry Hub | February 10, 2020 |

The Pharmacy Guild of Australia welcomes the renewed push by Health Minister, Greg Hunt, to achieve a national system of real time opioid prescription monitoring by the end of 2020.

The Pharmacy Guild has long supported and called for the introduction of national real time recording of controlled drugs, a move which will benefit vulnerable patients and provide significant clinical decision-making support for doctors and pharmacists.

A national, uniform real-time monitoring system, will enable pharmacists to identify and support patients at risk of dependence and will also help to counter doctor shopping.

National President of the Pharmacy Guild of Australia, George Tambassis said: “We wholeheartedly welcome Minister Hunt’s declaration that real time recording across Australia is a matter of priority.

“Some States and Territories have already developed systems, but we need all jurisdictions on board and systems that talk to each other to ensure a nationally effective approach,” said Mr Tambassis.

“Victoria’s Safescript is evidence of the effectiveness of real time monitoring in reducing high-risk opioid doses. As a result of this program, high-risk opioid doses is reported to have decreased 25 per cent between April and October last year,” he said.

“Community pharmacists and the Guild stand ready to work with State and Territory Governments to make this a reality as soon as possible. We have to get this done,” Mr Tambassis said.

Enhance corporate branding and boost thought leadership to attract and retain quality employees. Health Industry Hub is the only one-stop-hub connecting Australia’s Pharma, MedTech, and Biotech industry professionals. Get started with our proven digital media solutions developed by industry for industry.

Register FREE to receive the latest news, innovations and insights from Health Industry Hub; the only one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals and its key stakeholders.

You may also like New PBS listings to bring hope for Australians living with kidney disease, cystic fibrosis and cancer


News & Trends - MedTech & Diagnostics

Stryker partners with local researchers to advance shoulder joint surgery

Stryker partners with local researchers to advance shoulder joint surgery

Health Industry Hub | May 3, 2024 |

MedTech & Diagnostics News: Joint replacement is a commonly performed major surgical procedure that has considerable success in alleviating pain […]

More


News & Trends - Pharmaceuticals

Over two-thirds of Aussies missing healthcare appointments

Over two-thirds of Aussies missing healthcare appointments

Health Industry Hub | May 3, 2024 |

Pharma News: Over 70% of Australians have postponed or cancelled healthcare appointments in the last 12 months. The primary reason […]

More


News & Trends - Pharmaceuticals

Opposition decries incremental change as New Zealand government defends Pharmac budget

Opposition decries incremental change as New Zealand government defends Pharmac budget

Health Industry Hub | May 3, 2024 |

Pharma News: New Zealand’s Associate Health Minister has made headlines by unveiling Pharmac’s largest ever budget of $6.294 billion over […]

More


Medical

Telehealth's 10-year leap in 10 days: Reshaping hospital EDs

Telehealth’s 10-year leap in 10 days: Reshaping hospital EDs

Health Industry Hub | May 3, 2024 |

Medical: As overcrowding and ramping continue to challenge emergency departments across Australia, the concept of virtual emergency departments (EDs) emerges […]

More


This content is copyright protected. Please subscribe to gain access.